Cancer ResearchMar 23, 2021|2 min readBy DDNews StaffAsher Bio bursts on the scene with $55M Series AAsher Bio focuses on cis-targeting technology to precisely target discrete immune cell subtypes
ImmunologyJan 08, 2021|2 min readBy DDNews StaffDiCE Molecules bags $80M in a Series CThe financing will support the progression of DiCE’s IL-17 antagonist into clinical trials